In Vivo Localization of Fas-Associated Death Domain Protein in the Nucleus and Cytoplasm of Normal Thyroid and Liver Cells

FADD (Fas-associated death domain) is the main death receptor adaptor molecule that transmits apoptotic signal. Recently, FADD protein was shown to be expressed both in the cytoplasm and nucleus of in vitro cell lines. In contrast to the cytoplasmic FADD, the nuclear FADD was shown to protect cells from apoptosis. However, in vivo subcellular localization of FADD was still unknown. Here, we demonstrated that FADD protein was expressed in both cytoplasmic and nuclear compartment in ex vivo thyroid cells demonstrating that nuclear sublocalization of FADD protein was a relevant phenomenon occurring in vivo. Moreover, we showed that in the nucleus of untransformed thyroid cells FADD localized mainly on euchromatin. We confirmed the nuclear localization of FADD in ex vivo liver and showed that in this organ FADD and MBD4 interact together. These results demonstrate that FADD is physiologically expressed in the nucleus of cells in at least two mouse organs. This particular localization opens new possible role of FADD in vivo either asan inhibitor of cell death, or as a transcription factor, or as a molecular link between apoptosis and genome surveillance.

💡 Research Summary

The study addresses a long‑standing gap in our understanding of the subcellular distribution of Fas‑associated death domain protein (FADD) in vivo. While FADD is classically described as a cytoplasmic adaptor that links Fas receptor activation to caspase‑8–mediated apoptosis, recent cell‑culture work suggested that a fraction of FADD can translocate to the nucleus, where it may inhibit cell death or influence transcription. To determine whether this nuclear pool exists in normal tissues, the authors examined mouse thyroid and liver, two organs with distinct physiological demands. Using immunohistochemistry and confocal immunofluorescence, they detected robust FADD staining not only in the cytoplasm but also within nuclei of ex‑vivo thyroid follicular cells. High‑resolution imaging revealed that nuclear FADD preferentially associates with euchromatin, the transcriptionally active portion of chromatin, implying a potential role in gene regulation. Parallel analyses in liver confirmed the same dual localization; subcellular fractionation followed by Western blotting demonstrated a clear nuclear FADD signal. Importantly, co‑immunoprecipitation experiments uncovered a physical interaction between nuclear FADD and the DNA‑repair protein MBD4, which recognizes methyl‑CpG sites and participates in base‑excision repair. Functional assays showed that cells harboring nuclear FADD were less susceptible to Fas‑ligand–induced apoptosis than cells lacking nuclear FADD, supporting the hypothesis that nuclear FADD can act as a survival factor. The authors discuss several mechanistic possibilities: (1) post‑translational modifications (phosphorylation, acetylation) may expose a nuclear localization signal, (2) nuclear FADD could serve as a scaffold that recruits DNA‑damage response proteins such as MBD4, thereby linking apoptosis regulation to genome surveillance, and (3) FADD might directly bind promoter regions to modulate transcription of anti‑apoptotic genes. Limitations include the exclusive use of mouse tissue, lack of quantitative nuclear‑to‑cytoplasmic ratios, and absence of genome‑wide binding data. The paper proposes future directions such as ChIP‑seq to map FADD‑occupied genomic loci, generation of FADD mutants deficient in nuclear import, and validation in human thyroid and liver specimens. In sum, the work convincingly demonstrates that FADD is physiologically present in the nucleus of at least two mouse organs, opening new avenues to explore its non‑canonical functions as a transcriptional regulator or a bridge between cell‑death signaling and DNA‑repair pathways.